Filtered By:
Infectious Disease: Hepatitis C
This page shows you your search results in order of date. This is page number 14.
Order by Relevance | Date
Total 11826 results found since Jan 2013.
Real-world effectiveness and safety of direct-acting antivirals in hepatitis C virus patients with mental disorders
CONCLUSION: DAA treatment is safe and effective in HCV-infected patients with mental disorders. No specific psychiatric diagnosis lowered the chance of successful antiviral treatment.PMID:37476581 | PMC:PMC10354581 | DOI:10.3748/wjg.v29.i25.4085
Source: World Journal of Gastroenterology : WJG - July 21, 2023 Category: Gastroenterology Authors: Dorota Dybowska Dorota Zar ębska-Michaluk Piotr Rzymski Hanna Berak Beata Lorenc Marek Sitko Micha ł Dybowski W łodzimierz Mazur Magdalena Tudrujek-Zdunek Justyna Janocha-Litwin Ewa Janczewska Jakub Klapaczy ński Anna Parfieniuk-Kowerda Anna Piekarska Source Type: research
Evaluating the risk of infections under interleukin 23 and interleukin 17 inhibitors relative to tumour necrosis factor inhibitors - A population-based study
CONCLUSION: Compared with TNFi, IL-23i and IL-17i are associated with decreased risk of several infectious diseases. These agents might be preferred in patients with susceptibility to infections.PMID:37466275 | DOI:10.1111/jdv.19328
Source: Herpes - July 19, 2023 Category: Infectious Diseases Authors: Khalaf Kridin Henner Zirpel Noor Mruwat Ralf J Ludwig Diamant Thaci Source Type: research
Increasing Treatment Rates for Hepatitis C in Primary Care
CONCLUSION: A multifaceted primary care improvement initiative increased clinician confidence and was associated with an increase in the proportion of HCV RNA positive patients who initiated curative treatment.PMID:37468214 | DOI:10.3122/jabfm.2022.220427R1
Source: American Family Physician - July 19, 2023 Category: Primary Care Authors: Ann Stewart Amy Craig-Neil Kathryn Hodwitz Rick Wang Doret Cheng Gordon Arbess Caroline Jeon Clara Juando-Prats Tara Kiran Source Type: research
Evaluating the risk of infections under interleukin 23 and interleukin 17 inhibitors relative to tumour necrosis factor inhibitors - A population-based study
CONCLUSION: Compared with TNFi, IL-23i and IL-17i are associated with decreased risk of several infectious diseases. These agents might be preferred in patients with susceptibility to infections.PMID:37466275 | DOI:10.1111/jdv.19328
Source: Herpes - July 19, 2023 Category: Infectious Diseases Authors: Khalaf Kridin Henner Zirpel Noor Mruwat Ralf J Ludwig Diamant Thaci Source Type: research
Increasing Treatment Rates for Hepatitis C in Primary Care
CONCLUSION: A multifaceted primary care improvement initiative increased clinician confidence and was associated with an increase in the proportion of HCV RNA positive patients who initiated curative treatment.PMID:37468214 | DOI:10.3122/jabfm.2022.220427R1
Source: American Family Physician - July 19, 2023 Category: Primary Care Authors: Ann Stewart Amy Craig-Neil Kathryn Hodwitz Rick Wang Doret Cheng Gordon Arbess Caroline Jeon Clara Juando-Prats Tara Kiran Source Type: research
